228 related articles for article (PubMed ID: 28760903)
1. Tetrazole-Based
Alumasa JN; Goralski TDP; Keiler KC
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760903
[No Abstract] [Full Text] [Related]
2. Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model.
Louie A; VanScoy BD; Brown DL; Kulawy RW; Heine HS; Drusano GL
Antimicrob Agents Chemother; 2012 Mar; 56(3):1229-39. PubMed ID: 22155821
[TBL] [Abstract][Full Text] [Related]
3. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI
Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989
[TBL] [Abstract][Full Text] [Related]
4. Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture.
Alvarez Z; Lee K; Abel-Santos E
Antimicrob Agents Chemother; 2010 Dec; 54(12):5329-36. PubMed ID: 20921305
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization and evaluation of protective efficacy of EA752-862 monoclonal antibody against B. anthracis vegetative cell and spores.
Majumder S; Das S; Kingston J; Shivakiran MS; Batra HV; Somani VK; Bhatnagar R
Med Microbiol Immunol; 2020 Apr; 209(2):125-137. PubMed ID: 31811379
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system.
Louie A; Vanscoy BD; Heine HS; Liu W; Abshire T; Holman K; Kulawy R; Brown DL; Drusano GL
Antimicrob Agents Chemother; 2012 Jan; 56(1):513-7. PubMed ID: 22064542
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare.
Jones ME; Goguen J; Critchley IA; Draghi DC; Karlowsky JA; Sahm DF; Porschen R; Patra G; DelVecchio VG
Clin Microbiol Infect; 2003 Sep; 9(9):984-6. PubMed ID: 14616693
[TBL] [Abstract][Full Text] [Related]
8. Identification of an in vivo inhibitor of Bacillus anthracis spore germination.
Akoachere M; Squires RC; Nour AM; Angelov L; Brojatsch J; Abel-Santos E
J Biol Chem; 2007 Apr; 282(16):12112-8. PubMed ID: 17296608
[TBL] [Abstract][Full Text] [Related]
9. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
[TBL] [Abstract][Full Text] [Related]
10. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.
Wang W; Mulakala C; Ward SC; Jung G; Luong H; Pham D; Waring AJ; Kaznessis Y; Lu W; Bradley KA; Lehrer RI
J Biol Chem; 2006 Oct; 281(43):32755-64. PubMed ID: 16790431
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli.
Crawford MA; Zhu Y; Green CS; Burdick MD; Sanz P; Alem F; O'Brien AD; Mehrad B; Strieter RM; Hughes MA
Infect Immun; 2009 Apr; 77(4):1664-78. PubMed ID: 19179419
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE
Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204
[TBL] [Abstract][Full Text] [Related]
13. Bacillus anthracis spore interactions with mammalian cells: relationship between germination state and the outcome of in vitro.
Gut IM; Tamilselvam B; Prouty AM; Stojkovic B; Czeschin S; van der Donk WA; Blanke SR
BMC Microbiol; 2011 Feb; 11():46. PubMed ID: 21356113
[TBL] [Abstract][Full Text] [Related]
14. Effects of L-alanine and inosine germinants on the elasticity of Bacillus anthracis spores.
Pinzón-Arango PA; Nagarajan R; Camesano TA
Langmuir; 2010 May; 26(9):6535-41. PubMed ID: 20095533
[TBL] [Abstract][Full Text] [Related]
15. The impact of inducing germination of Bacillus anthracis and Bacillus thuringiensis spores on potential secondary decontamination strategies.
Omotade TO; Bernhards RC; Klimko CP; Matthews ME; Hill AJ; Hunter MS; Webster WM; Bozue JA; Welkos SL; Cote CK
J Appl Microbiol; 2014 Dec; 117(6):1614-33. PubMed ID: 25196092
[TBL] [Abstract][Full Text] [Related]
16. Effective antiprotease-antibiotic treatment of experimental anthrax.
Popov SG; Popova TG; Hopkins S; Weinstein RS; MacAfee R; Fryxell KJ; Chandhoke V; Bailey C; Alibek K
BMC Infect Dis; 2005 Apr; 5():25. PubMed ID: 15819985
[TBL] [Abstract][Full Text] [Related]
17. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
Welkos S; Little S; Friedlander A; Fritz D; Fellows P
Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
[TBL] [Abstract][Full Text] [Related]
18. Potential use of inhibitors of bacteria spore germination in the prophylactic treatment of anthrax and Clostridium difficile-associated disease.
Alvarez Z; Abel-Santos E
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):783-92. PubMed ID: 17914913
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule inhibitors of lethal factor protease activity protect against anthrax infection.
Moayeri M; Crown D; Jiao GS; Kim S; Johnson A; Leysath C; Leppla SH
Antimicrob Agents Chemother; 2013 Sep; 57(9):4139-45. PubMed ID: 23774434
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Daptomycin against Bacillus anthracis in a murine model of anthrax spore inhalation.
Heine HS; Bassett J; Miller L; Purcell BK; Byrne WR
Antimicrob Agents Chemother; 2010 Oct; 54(10):4471-3. PubMed ID: 20643899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
